US Edition
Bayer proposes US$10.25 billion plan for all Roundup cancer cases
Bayer aims to resolve about 65,000 current and future claims with a $7.25 billion fund, plus $3 billion for other cases, requiring court approval.
- On Tuesday, Bayer's Monsanto unit filed a proposed $7.25 billion nationwide class settlement in St. Louis Circuit Court to resolve current and future Non-Hodgkin lymphoma claims.
- The move follows the U.S. Supreme Court agreeing to hear Bayer's failure-to-warn appeal, with oral arguments set for April 27, as Bayer argues federal law preempts state failure-to-warn suits under EPA-approved labels.
- The deal creates a long-term claims program with capped annual payments over 17 to 21 years, distributing compensation via a tiered grid with average awards up to $165,000 and maximum awards of $198,000.
- Bayer postponed publication of its 2025 results and 2026 guidance to March 4 as it reflected the agreements, warning provisions will rise to 11.8 billion euros and shares jumped after the announcement.
- A favorable Supreme Court ruling could wipe out several large verdicts on appeal and sharply limit Bayer's liability, while approximately 65,000 plaintiffs still have pending claims after prior $10 billion payouts.
163 Articles
163 Articles
Yesterday cheering on the stock market - not 24 hours later disillusionment. After the billion-dollar glyphosate comparison, investors struggle with the question: Is this a liberation strike or just a respite for Bayer?
The company has closed a billion-dollar comparison with Glyphosate prosecutors in the USA. No reason for euphoria. There are still a few hurdles.
The next billion-dollar comparison around the weed destroyer glyphosate increases the chances for the chemical company to get rid of the legal risks, but the price is high.
Hawaii Tribune-Herald
The Daily WireBayer proposes $7.25 billion plan to settle Roundup cancer cases
Bayer said on Tuesday its Monsanto unit had reached an agreement worth as much as $7.25 billion to resolve tens of thousands of current and future lawsuits claiming that its Roundup weedkiller caused cancer.
The Billings Gazette
Omaha World-Herald$7.25B settlement over weedkiller proposed
JEFFERSON CITY, Mo. — Agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve thousands of U.S. lawsuits alleging the company failed to warn people that its popular weedkiller Roundup could cause cancer.
At $7.25 billion, Bayer wants to finally settle the case against Roundup. Shareholders are breathing up.
Coverage Details
Bias Distribution
- 69% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
